Abstract
High-dose chemotherapy with autologous bone marrow and/or peripheral blood stem cell (PBSC)support is increasingly employed in the adjuvant treatment of high-risk breast cancer. Subsequent radiotherapy has been reported to be associated with morbidity and mortality resulting from pulmonary toxicity. In addition, the course of radiation therapy may be hampered by
... read more